Join BJS Academy
BJS Academy>Randomized clinical ...>Pain outcomes follow...
Normal View Dyslexic View

Pain outcomes following mechanochemical ablation vs cyanoacrylate adhesive for the treatment of primary truncal saphenous vein incompetence. The MOCCA randomized clinical trial.

28 July 2022
Randomized clinical trials Vascular
Belramman A, Bootun R, Tang TY, Lane TRA, Davies AH.

JAMA Surg 2022; 157: 395-404.

Pain scores were similar after both of these non tumescent venous ablation methods in this study that included 167 procedures. Both methods improved disease-specific quality of life.

Comment: Late clinical outcomes will be important.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct206
Randomized clinical trials
Randomized clinical trials
Vascular
Pain outcomes following mechanochemical ablation vs cyanoacrylate adhesive for the treatment of primary truncal saphenous vein incompetence. The MOCCA randomized clinical trial.
Belramman A, Bootun R, Tang TY, Lane TRA, Davies AH.
28072022
JAMA Surg 2022; 157: 395-404.
Pain scores were similar after both of these non tumescent venous ablation methods in this study that included 167 procedures. Both methods improved disease-specific quality of life.
Comment: Late clinical outcomes will be important.
Published on: 28 July 2022
Article ID: rct206

Related articles

Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial.

Terlouw LG, van Dijk LJD, van Noord D, Bakker OJ, Bijdevaate DC, Erler NS et al, on behalf of the Dutch Mesenteric Ischemia Study Group.

16 August 2024

Ten-year outcomes of a randomized clinical trial of endothermal ablation versus conventional surgery for great saphenous varicose veins

Mohamed AH, Howitt A, Rae S, Cai PL, Hitchman L, Wallace T et al.

18 September 2024

Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism. The Kids-DOTT randomized clinical trial.

Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA et al, for the Kids-DOTT Trial investigators and the ATLAS Group.
JAMA 2022; 327: 129-137.

1 February 2022
Home
  • Normal view
  • Dyslexic view
Info
Copied!